MIKKELSEN; Jens Damsgaard

Patent Applications and Registrations

Patent applications and USPTO patent grants for MIKKELSEN; Jens Damsgaard.The latest application filed is for "peptide agonists of glp-1 activity".

Company Profile

1.5.20

MIKKELSEN; Jens Damsgaard - Kgs. Lyngby DK
MIKKELSEN; JENS DAMSGAARD - LYNGBY DK
Mikkelsen; Jens Damsgaard - Ballerup DK

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Peptide Agonists Of Glp-1 Activity App 20180362611 - LARSEN; Bjarne Due ; et al.	2018-12-20
Peptide Agonists Of Glp-1 Activity App 20170107267 - LARSEN; Bjarne Due ; et al.	2017-04-20
Exendin variant peptides Grant RE45,313 - Larsen , et al. December 30, 2	2014-12-30
Methods For Using Peptide Agonists Having Glp-1 Activity App 20130210722 - LARSEN; BJARNE DUE ; et al.	2013-08-15
1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical use Grant 8,372,832 - Peters , et al. February 12, 2	2013-02-12
1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use Grant 8,343,960 - Peters , et al. January 1, 2	2013-01-01
Labelled Pyrrolyl-oxadiazolyl-diazabicyclononane Derivatives And Their Use In Diagnostic Methods App 20120288443 - Peters; Dan ; et al.	2012-11-15
1,4-diaza-bicyclo[3.2.2]nonyl Oxadiazolyl Compounds And Their Medical Use App 20120172353 - PETERS; Dan ; et al.	2012-07-05
Peptide Agonists Of Glp-1 Activity App 20110245165 - LARSEN; Bjarne Due ; et al.	2011-10-06
Peptide Agonists Of Glp-1 Activity App 20110144008 - LARSEN; Bjarne Due ; et al.	2011-06-16
Method For Treating Over-eating Disorders App 20110118304 - Mikkelsen; Jens Damsgaard ; et al.	2011-05-19
Novel Oxadiazolyl-diazabicyclononane Derivatives And Their Medical Use App 20110112078 - Peters; Dan ; et al.	2011-05-12
Azabicyclooctyl-quinazolone Derivatives Useful As Nicotinic Acetylcholine Receptor Modulators App 20110112119 - Peters; Dan ; et al.	2011-05-12
Novel 1,4-diaza-bicyclo[3.2.2]nonyl Pyrimidine Derivatives And Their Medical Use App 20110046118 - Peters; Dan ; et al.	2011-02-24
Pharmaceutical Composition Comprising Tesofensine Or Its Analogue And An Anti-obesity Compound App 20100317572 - Mikkelsen; Jens Damsgaard	2010-12-16
Novel 1,4-diaza-bicyclo[3.2.2]nonyl Pyrimidine Derivatives And Their Medical Use App 20100305108 - Peters; Dan ; et al.	2010-12-02
Novel 1,4-diaza-bicyclo[3.2.2]nonyl Pyrimidine Derivatives And Their Medical Use App 20100298307 - Peters; Dan ; et al.	2010-11-25
Novel 1,4-diaza-bicyclo[3.2.2]nonyl Oxadiazolyl Derivatives And Their Medical Use App 20100216780 - Peters; Dan ; et al.	2010-08-26
Novel 1,4-diaza-bicyclo[3.2.2]nonyl Pyrimidinyl Derivatives And Their Medical Use App 20090197872 - Peters; Dan ; et al.	2009-08-06
Peptide agonists of GLP-1 activity App 20070111940 - Larsen; Bjarne Due ; et al.	2007-05-17
Method for screening for compounds as potential sedatives or anxiolytics App 20060013770 - Mikkelsen; Jens Damsgaard	2006-01-19
Method of treating metabolic disorders using neuronatin polypeptides App 20040259777 - Thirstrup, Kenneth ; et al.	2004-12-23
Novel peptide agonists of GLP-1 activity App 20040106547 - Larsen, Bjarne Due ; et al.	2004-06-03
Peptide agonists of GLP-1 activity Grant 6,528,486 - Larsen , et al. March 4, 2	2003-03-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.